IM Cannabis to Sell European Assets
IM Cannabis Corp. announced an agreement to sell its subsidiary IMC Holdings and European-focused assets. The transaction is expected to improve the company's equity by approximately CAD$3 million.
IM Cannabis Corp. announced today that it has entered into an agreement to sell its subsidiary, IMC Holdings, along with its European-focused assets. The sale is projected to enhance the company's shareholders' equity by approximately CAD$3 million.
Specific details regarding the terms of the transaction and the identity of the buyer have not yet been disclosed. IM Cannabis has previously operated in various European markets, including Germany, the Netherlands, and the Czech Republic, concentrating on the import and distribution of medical cannabis.
This divestiture is part of IM Cannabis's broader strategic repositioning. The company aims to sharpen its focus on the North American markets, particularly within the expanding cannabis sectors of Canada and the United States. The company had previously signaled its intention to divest these European assets to improve its financial standing.
The cannabis industry has faced considerable market volatility, prompting many companies, including IM Cannabis, to reassess their operational strategies and financial structures. This move aligns with a trend of consolidation and strategic realignment within the sector.